Immunogenetics and immunotherapy in autoinflammatory and immune responses
News
Research
A new CAR-T therapy shows efficacy in preclinical models of hard-to-treat leukemias
Researchers from Clínic-IDIBAPS, within the Clínic Barcelona Comprehensive Cancer Center, and the spin-off Gyala Therapeutics have coordinated a stud1
Research
The gut microbiota, key to improving the effectiveness of CAR T-cell therapy in multiple myeloma
A study led by the Clínic-IDIBAPS reveals that the microbiota can predict and enhance patient response to one of the most innovative immunotherapies1